Semaglutide is a prescription medication that belongs to a class of drugs called GLP-1 receptor agonists
What if I am pregnant or planning to become pregnant
Second, existing GLP-1 medications like semaglutide already have approval for type 2 diabetes, so retatrutide would be entering a market with established competitors but potentially superior efficacy
Injection sites: Abdomen, thigh, upper arm anywhere with subcutaneous fat Volume: 0.1 mL with an insulin syringe (29-31 gauge) Not oral: PT-141 is a cyclic peptide degraded by stomach acid Not nasal: Early research explored nasal delivery, but SC proved more reliable Reconstitution Quick Reference Math: 10 mg / 2 mL = 5 mg/mL = 5,000 mcg/mL
Challenges: The key challenge for Sanofi is competition from more established and better marketed GLP-1 drugs, particularly those from Novo Nordisk and Eli Lilly
Night sweats are not listed as a recognised side effect in Mounjaro's official Summary of Product Characteristics, and no causal link has been established in clinical trials